| scholarly article | Q13442814 |
| P50 | author | Anne C Staff | Q87163921 |
| Gabriela Barrientos | Q59661686 | ||
| Ralf Dechend | Q63812628 | ||
| Sandra M Blois | Q45749004 | ||
| P2860 | cites work | Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein | Q22010697 |
| Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 | ||
| A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death | Q24317162 | ||
| NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin | Q24561606 | ||
| A redox switch in angiotensinogen modulates angiotensin release | Q24594061 | ||
| Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy | Q24645245 | ||
| Intracellular functions of galectins | Q28201120 | ||
| Ah, sweet mystery of death! Galectins and control of cell fate | Q28203010 | ||
| Functional analyses of placental protein 13/galectin-13 | Q28249207 | ||
| Cubilin, a binding partner for galectin-3 in the murine utero-placental complex | Q28513926 | ||
| Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation | Q28592073 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells | Q74188076 | ||
| Galectin-1 and -3 in cells of the first trimester placental bed | Q74510168 | ||
| Spatio-temporal pattern for expression of galectin-3 in the murine utero-placental complex: evidence for differential regulation | Q74593540 | ||
| Renin-like immunoreactivity in uterus and placenta from normotensive and hypertensive pregnancies | Q78171457 | ||
| Acute atherosis in decidual tissue: not associated with systemic oxidative stress in preeclampsia | Q79543767 | ||
| Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells | Q80557226 | ||
| The risk of maternal ischaemic heart disease after gestational hypertensive disease | Q81352777 | ||
| Putting pressure on pre-eclampsia | Q81752844 | ||
| A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound | Q82068160 | ||
| Expression of galectin-3 in mouse endometrium and its effect during embryo implantation | Q82689401 | ||
| Galectin-3 enhances proliferation and angiogenesis of endothelial cells differentiated from bone marrow mesenchymal stem cells | Q82978710 | ||
| Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key | Q83038278 | ||
| First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia | Q85029222 | ||
| Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia | Q63441869 | ||
| The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women | Q67541847 | ||
| A prospective study of plasma-renin activity in normal and toxaemic pregnancy | Q70103183 | ||
| Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice | Q71666048 | ||
| Immunohistochemical localization of a beta-D-galactoside-binding lectin at the human maternofetal interface | Q72806537 | ||
| Reproductive tissue renin gene expression in preeclampsia | Q73300232 | ||
| Uterine DCs are crucial for decidua formation during embryo implantation in mice | Q30484560 | ||
| VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis | Q31121321 | ||
| PP13 mRNA expression in trophoblasts from preeclamptic placentas | Q33393566 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy | Q33893203 | ||
| Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study | Q33947553 | ||
| Galectin-1 is part of human trophoblast invasion machinery--a functional study in vitro. | Q34103149 | ||
| Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia | Q34328411 | ||
| Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study | Q34341543 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions | Q35015992 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells | Q35314084 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| HLA-G and immune tolerance in pregnancy | Q36109416 | ||
| Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells | Q36184194 | ||
| Roles of galectin-3 in immune responses. | Q36366397 | ||
| Galectin-1: a small protein with major functions | Q36535706 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer | Q36884492 | ||
| Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. | Q36910837 | ||
| Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia | Q37010679 | ||
| AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia | Q37132801 | ||
| Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies | Q37218199 | ||
| Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse | Q37281164 | ||
| Severe preeclampsia is characterized by increased placental expression of galectin-1 | Q37416956 | ||
| Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. | Q37416997 | ||
| Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function | Q37434727 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| The global impact of pre-eclampsia and eclampsia | Q37493240 | ||
| Immunology of pre-eclampsia | Q37717752 | ||
| Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health | Q37801230 | ||
| Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses | Q38067951 | ||
| Redefining preeclampsia using placenta-derived biomarkers. | Q38086495 | ||
| Involvement of galectin-1 in reproduction: past, present and future | Q38146856 | ||
| Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors | Q38152072 | ||
| IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease | Q38177462 | ||
| IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? | Q38183247 | ||
| Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas | Q38299585 | ||
| Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells | Q38334060 | ||
| Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages | Q38758852 | ||
| Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy | Q39273203 | ||
| Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1. | Q39676276 | ||
| Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia | Q39712205 | ||
| Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death | Q40333858 | ||
| Cloning and nucleotide sequence of a full-length cDNA for human 14 kDa beta-galactoside-binding lectin | Q42646004 | ||
| Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early Toxoplasma gondii infection. | Q43282966 | ||
| Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss | Q43817587 | ||
| Tumor cells secrete galectin-1 to enhance endothelial cell activity. | Q44132717 | ||
| Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia | Q44357244 | ||
| Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies | Q44968495 | ||
| Decidual vasculopathy in preeclampsia: lesion characteristics relate to disease severity and perinatal outcome | Q45164682 | ||
| Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation | Q45244862 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents | Q45783688 | ||
| Effects of circulating and local uteroplacental angiotensin II in rat pregnancy | Q46588322 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| A pivotal role for galectin-1 in fetomaternal tolerance | Q46891030 | ||
| Tall or short? Twenty years after preeclampsia exposure in utero: comparisons of final height, body mass index, waist-to-hip ratio, and age at menarche among women, exposed and unexposed to preeclampsia during fetal life | Q47209473 | ||
| Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother | Q47847189 | ||
| Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 | ||
| Angiotensin-forming enzyme in brain tissue | Q48805828 | ||
| Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance. | Q52187455 | ||
| Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. | Q52192828 | ||
| Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. | Q52900457 | ||
| Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. | Q53754044 | ||
| Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. | Q54616145 | ||
| Angiotensin blood levels in normal and toxemic pregnancies. | Q54720175 | ||
| Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. | Q55053962 | ||
| Placental Protein 13 and Decidual Zones of Necrosis: An Immunologic Diversion That May be Linked to Preeclampsia | Q56794716 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Single Nucleotide Polymorphisms in G Protein Signaling Pathway Genes in Preeclampsia | Q57671284 | ||
| P433 | issue | 1 | |
| P921 | main subject | pathophysiology | Q1135939 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 39-50 | |
| P577 | publication date | 2014-09-06 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia | |
| P478 | volume | 72 |
Search more.